Early stage life sciences company iBIONICS has had “a phenomenal year of growth and learning,” says CEO and co-founder Suzanne Grant.
The company, which is developing a bionic-eye system to restore vision in people with retinal degenerative diseases, has reached combined private and public funding goals of US$2.5 million and added another $1.5 million in grants; it also expects to finalize additional pre-seed financing in the next two quarters.
The firm has secured an exclusive worldwide licence for its prototype and has recently celebrated several other business and technical milestones.
OBJ360 (Sponsored)
Legal tips for making workplace changes during a period of economic uncertainty
With the ongoing threat of severe trade disruptions and economic uncertainty in the air, business owners who have been economically impacted by the tariffs might be contemplating changes to their
Get more at home in Weavers Way, Almonte, by Minto
Weavers Way, Almonte, is Minto’s newest community, offering homebuyers a charming small-town lifestyle with big-city convenience. Stroll through historic made-for-the-movies downtown lined with boutiques and cafés, or explore scenic trails
Ms. Grant and iBIONICS were also chosen to exhibit at the Accessibility Innovation Showcase at the Invictus Games in Toronto in September.
